Ikeda M - Search Results

1

Pharmacodynamic Biomarkers Predictive of Survival Benefit with Lenvatinib in Unresectable Hepatocellular Carcinoma: From the Phase III REFLECT Study.

Finn RS, Kudo M, Cheng AL, Wyrwicz L, Ngan RKC, Blanc JF, Baron AD, Vogel A, Ikeda M, Piscaglia F, Han KH, Qin S, Minoshima Y, Kanekiyo M, Ren M, Dairiki R, Tamai T, Dutcus CE, Ikezawa H, Funahashi Y, Evans TRJ. Finn RS, et al. Among authors: ikeda m. Clin Cancer Res. 2021 Sep 1;27(17):4848-4858. doi: 10.1158/1078-0432.CCR-20-4219. Epub 2021 Jun 9. Clin Cancer Res. 2021. PMID: 34108184 Free PMC article. Clinical Trial.

2

Phase I and pharmacokinetic study of 5-fluorouracil administered by 5-day continuous infusion in patients with hepatocellular carcinoma.

Ueno H, Okada S, Okusaka T, Ikeda M, Kuriyama H. Ueno H, et al. Among authors: ikeda m. Cancer Chemother Pharmacol. 2002 Feb;49(2):155-60. doi: 10.1007/s00280-001-0400-8. Epub 2001 Nov 28. Cancer Chemother Pharmacol. 2002. PMID: 11862430 Clinical Trial.

3

Satellite lesions in patients with small hepatocellular carcinoma with reference to clinicopathologic features.

Okusaka T, Okada S, Ueno H, Ikeda M, Shimada K, Yamamoto J, Kosuge T, Yamasaki S, Fukushima N, Sakamoto M. Okusaka T, et al. Among authors: ikeda m. Cancer. 2002 Nov 1;95(9):1931-7. doi: 10.1002/cncr.10892. Cancer. 2002. PMID: 12404287 Free article.

4

Prognostic factors in patients with small hepatocellular carcinoma treated by percutaneous ethanol injection.

Kuriyama H, Okada S, Okusaka T, Ueno H, Ikeda M. Kuriyama H, et al. Among authors: ikeda m. J Gastroenterol Hepatol. 2002 Nov;17(11):1205-10. doi: 10.1046/j.1440-1746.2002.02807.x. J Gastroenterol Hepatol. 2002. PMID: 12453281

5

Prognostic factors in patients with hepatocellular carcinoma treated by transcatheter arterial embolization.

Ikeda M, Okada S, Yamamoto S, Sato T, Ueno H, Okusaka T, Kuriyama H, Takayasu K, Furukawa H, Iwata R. Ikeda M, et al. Jpn J Clin Oncol. 2002 Nov;32(11):455-60. doi: 10.1093/jjco/hyf097. Jpn J Clin Oncol. 2002. PMID: 12499417

6

[Chemotherapy for hepatocellular carcinoma].

Okusaka T, Ueno H, Ikeda M. Okusaka T, et al. Among authors: ikeda m. Gan To Kagaku Ryoho. 2004 Dec;31(13):2122-8. Gan To Kagaku Ryoho. 2004. PMID: 15628756 Review. Japanese.

7

A phase II trial of continuous infusion of 5-fluorouracil, mitoxantrone, and cisplatin for metastatic hepatocellular carcinoma.

Ikeda M, Okusaka T, Ueno H, Takezako Y, Morizane C. Ikeda M, et al. Cancer. 2005 Feb 15;103(4):756-62. doi: 10.1002/cncr.20841. Cancer. 2005. PMID: 15637692 Free article. Clinical Trial.

8

Severe drug toxicity associated with a single-nucleotide polymorphism of the cytidine deaminase gene in a Japanese cancer patient treated with gemcitabine plus cisplatin.

Yonemori K, Ueno H, Okusaka T, Yamamoto N, Ikeda M, Saijo N, Yoshida T, Ishii H, Furuse J, Sugiyama E, Kim SR, Kikura-Hanajiri R, Hasegawa R, Saito Y, Ozawa S, Kaniwa N, Sawada J. Yonemori K, et al. Among authors: ikeda m. Clin Cancer Res. 2005 Apr 1;11(7):2620-4. doi: 10.1158/1078-0432.CCR-04-1497. Clin Cancer Res. 2005. PMID: 15814642 Clinical Trial.

9

Spontaneous regression of hepatocellular carcinoma.

Kondo S, Okusaka T, Ueno H, Ikeda M, Morizane C. Kondo S, et al. Among authors: ikeda m. Int J Clin Oncol. 2006 Oct;11(5):407-11. doi: 10.1007/s10147-006-0591-4. Int J Clin Oncol. 2006. PMID: 17058140

10

Predictive factors of outcome and tumor response to systemic chemotherapy in patients with metastatic hepatocellular carcinoma.

Ikeda M, Okusaka T, Ueno H, Morizane C, Kojima Y, Iwasa S, Hagihara A. Ikeda M, et al. Jpn J Clin Oncol. 2008 Oct;38(10):675-82. doi: 10.1093/jjco/hyn087. Epub 2008 Aug 20. Jpn J Clin Oncol. 2008. PMID: 18716041

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,529 results

Search Page